Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
454.6 GBX | +2.85% | +2.25% | -6.65% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
04-19 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Sales 2024 * | 1.84B 2.3B 3.15B | Sales 2025 * | 1.98B 2.48B 3.39B | Capitalization | 1.43B 1.79B 2.44B |
---|---|---|---|---|---|
Net income 2024 * | 64M 80.13M 110M | Net income 2025 * | 91M 114M 156M | EV / Sales 2024 * | 0.77 x |
Net cash position 2024 * | 8.12M 10.17M 13.91M | Net cash position 2025 * | 13.65M 17.09M 23.38M | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
15.2
x | Employees | 7,859 |
Yield 2024 * |
5.27% | Yield 2025 * |
6.26% | Free-Float | 94.58% |
Latest transcript on PageGroup plc
1 day | +2.85% | ||
1 week | +2.25% | ||
Current month | +1.88% | ||
1 month | -8.79% | ||
3 months | +0.58% | ||
6 months | +10.29% | ||
Current year | -6.65% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Kirk
CEO | Chief Executive Officer | - | 22-12-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Kaye Maguire
LAW | General Counsel | - | 18-09-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marie Metayer
BRD | Director/Board Member | 64 | 17-08-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Karen Geary
BRD | Director/Board Member | - | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 454.6 | +2.85% | 524,706 |
24-05-08 | 442 | -1.07% | 333,857 |
24-05-07 | 446.8 | +0.81% | 275,536 |
24-05-03 | 443.2 | -0.27% | 157,358 |
24-05-02 | 444.4 | -0.04% | 309,304 |
Delayed Quote London S.E., May 09, 2024 at 11:35 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.65% | 1.73B | |
-10.35% | 1.86B | |
+9.52% | 644M |
- Stock Market
- Equities
- MPI Stock